EUCTR2010-019684-11-NL进行中（未招募）不适用
Pharmacological Treatment in Osteoarthritis
Maasstad Hospital0 个研究点开始时间: 2010年5月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age = 40 years
- •Primary hand OA according to the ACR classification
- •Heberden or Bouchard nodule or Kellgren-Lawrence grade 1, 2 or 3 in = 2 symptomatic joints
- •Pain in the dominant hand = 12 months
- •Use of an NSAID for = 1 episode of pain
- •Written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Secondary hand OA, e.g. hemochromatose, rheumatoid arthritis, posttraumatic
- •Kellgren-Lawrence grade 4 OA
- •Use of hydroxychloroquine within 3 months before entering the study
- •Use of NSAIDs or corticosteroids within 7 days before entering the study
- •Retinopathy
- •Known allergy or hypersensitivity for hydroxychloroquine
研究者
相似试验
已完成
3 期
Pharmacological Treatment in Hand Osteoarthritisgewrichtaandoeningdegenerative arthritisdegenerative joint diseaseNL-OMON38184Maasstadziekenhuis200
尚未招募
不适用
Farmacologische Behandeling in Osteoarthritis.hand osteoarthritisNL-OMON25343Maasstad Hospital200
招募中
1 期
Clinical trial on osteoarthritis using chondrocyte spheroids differentiated from adipose-derived mesenchymal stem cellsOsteoarthritisJPRN-jRCTb032220281Hayashi Shuji20
尚未招募
Unknown
Effect of Osteoarthritis Drugs on inflammatory markers and its relation with Clinical OutcomeCTRI/2023/04/051950Vardhman Mahavir Medical College and Safdarjung Hospital
进行中（未招募）
不适用
Treatment of osteoarthritis with allogeneic mesenchymal cells (MSV*).gonarthrosis (osteoarthritis)MedDRA version: 14.1Level: LLTClassification code 10048794Term: GonarthrosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2011-005321-51-ESParque Científico de la Universidad de Valladolid30